共 21 条
[1]
Salmon calcitonin: a review of current and future therapeutic indications
[J].
OSTEOPOROSIS INTERNATIONAL,
2008, 19 (04)
:479-491
Chesnut, C. H., III
;
Azria, M.
;
Silverman, S.
;
Engelhardt, M.
;
Olson, M.
;
Mindeholm, L.
.
[2]
Response Surface Methodology to Obtain &bgr;-Estradiol Biodegradable Microspheres for Long-Term Therapy of Osteoporosis.[J].Abdel-Azim Zaghloul;Fatima Mustafa;Afzal Siddiqui;Mansoor Khan.Pharmaceutical Development and Technology.2006, 3
[3]
Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D<Subscript>3</Subscript> (alfacalcidol) for treatment of postmenopausal bone loss.[J].Hideki Mizunuma;Masataka Shiraki;Masafumi Shintani;Itsuo Gorai;Kazuya Makita;Shunichi Itoga;Yoshiko Mochizuki;Hiromichi Mogi;Yasuhisa Iwaoki;Shouichirou Kosha;Toshiyuki Yasui;Osamu Ishihara;Takumi Kurabayashi;Yoshio Kasuga;Kunihiko Hayashi.Journal of Bone and Mineral Metabolism.2006, 1
[4]
A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6‐month study*.[J].A. W. C. Kung;E. G. Pasion;M. Sofiyan;E. M. C. Lau;B. K. Tay;K. S. Lam;K. Wilawan;B. Ongphiphadhanakul;D. Thiebaud.Current Medical Research and Opinion?.2006, 5
[5]
Statin but not non-statin lipid-lowering drugs decrease fracture risk: A nation-wide case-control study
[J].
CALCIFIED TISSUE INTERNATIONAL,
2006, 79 (01)
:27-36
Rejnmark, L.
;
Vestergaard, P.
;
Mosekilde, L.
.
[6]
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
[J].
BREAST CANCER RESEARCH AND TREATMENT,
2001, 65 (02)
:125-134
Cauley, JA
;
Norton, L
;
Lippman, ME
;
Eckert, S
;
Krueger, KA
;
Purdie, DW
;
Farrerons, J
;
Karasik, A
;
Mellstrom, D
;
Ng, KW
;
Stepan, JJ
;
Powles, TJ
;
Morrow, M
;
Costa, A
;
Silfen, SL
;
Walls, EL
;
Schmitt, H
;
Muchmore, DB
;
Jordan, VC
.
[7]
[8]
[9]
[10]